Here's How Much $100 Invested In ResMed 10 Years Ago Would Be Worth Today
Don’t Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain
ResMed: A Quality Compounder, But Not Yet A Bargain
ResMed: 3 Key Takeaways for Long-Term Investors
RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscape
ResMed (NYSE:RMD) Delivers Quality Dividend Strength for Income Investors
ResMed (RMD) Looks Fully Valued After Another Earnings Beat
Citigroup Maintains Neutral on ResMed, Raises Price Target to $270
ResMed (RMD) Q1 2027 Earnings Call Transcript
RBC Capital Maintains Outperform on ResMed, Raises Price Target to $288
Wells Fargo Maintains Equal-Weight on ResMed, Raises Price Target to $250
ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to Say
ResMed Inc. Q1 2027 Earnings Call Summary
Keybanc Maintains Overweight on ResMed, Raises Price Target to $277
ResMed Inc. Reports Q1 Fiscal Year 2027 Revenue of $1.4 billion and Declares Quarterly Cash Dividend of $0.66 per share
ResMed Inc. 2027 Q1 - Results - Earnings Call Presentation
ResMed Inc. (RMD) Q1 2027 Earnings Call Transcript
ResMed (NYSE:RMD) posts better-than-expected sales in Q3 CY2026
ResMed: Fiscal Q1 Earnings Snapshot
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.